Clinical Trials Browser

Phase 3 × Terminated × Prostate Cancer Metastatic × Clear all

NCT03850795 2024-08-19

HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Phase 3 Terminated

Prostate Cancer Metastatic